PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Go to 29mins and there is PAR's DMOAD stance and what they will...

  1. 832 Posts.
    lightbulb Created with Sketch. 331
    Go to 29mins and there is PAR's DMOAD stance and what they will be taking into the conference. He seriously can't make those statements if they dont truely believe with the proof. "you need this multiple acting drug which is what Zilosol does". So now it will be does this match the FDA's version of DMOAD (which hopefully our experts believe it does)...

    One thing about PR is that he seems like a gentleman and nice all round guy and his enthusiasium is undeniable. He has such a high level knowledge of Zilosol and Im guessing he better than anybody understands the size of the opportunity.

    The Pool
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.